Sometimes you have to unplug…
…in order to connect. As the podcast has grown, we have become aware of a need amongst the community to create ‘real world’ spaces where like-minded people can connect around the topic of Psychedelics. Too much of the day-to-day flow of our lives are conducted through the artifice of screens, but as social animals, we need to physically be around each other. It is with this need in mind that we have created the Summer Symposiums - a place where like-minded people come together. When it comes to psychedelics, no one group has all the answers, so we need to break bread and compare notes!
This sense of viewpoint diversity and need for connection is at the heart of the Summer Symposiums,
and we want you to be a part of it.
Sunday 6th Feb: ‘Non-Ordinary States for Ordinary Australians’
We are delighted to announce the line-up for the inaugural Summer Symposium, Sunday 6th Feb 2- 5.30 pm in Roleystone, Perth Hills.
Our topic is, “Non-Ordinary States for Ordinary Australians’, and our expert panel will be providing an overview of the current state of play for psychedelics in Australia - and beyond.
The panel will be discussing;
‘Where we are at’ with Psychedelic Research in Australia,
Financing options for the current Renaissance,
Clinical Care Models and Regulatory Pathways,
How to optimise the integration of these substances into Australian Society,
and many other topics…
This Podcast Panel discussion will be in front of a live audience, with opportunities for Q and A - followed by live music, canapes, drinks and chats on the deck overlooking the beautiful Perth Hills!
This free, invite-only event is being held at a private location in pristine bushland in the Perth Hills. Places are very limited for this intimate event, so click the link below to secure your spot today and receive your exclusive invite info pack. Click below to secure your spot!
Our Expert Panel
Dr Michael Winlo:
Managing Director @ Emyria
Dr. Michael Winlo is the Managing Director of Emyria, one of Australia’s most exciting drug development start-ups. Michael holds a Bachelor of Medicine and Bachelor of Surgery with Honours from the University of Western Australia as well as a Master of Business Administration from Stanford University. Prior to Emyria, Michael was CEO at Linear Clinical Research Ltd (Linear) – a company providing clinical trial services for US- and Asia-based biotech companies. Linear was the first site in Australia, and one of the first few in the world, to successfully adopt electronic data capture technology. Michael retains a Directorship at Linear. Prior to Linear, Michael was Health Lead at Palantir Technologies – a Big Data company based in Silicon Valley California Emyria are currently poised to become one of the foremost providers of psychedelic-assisted care in Australia.
Dr Jeremy Tannenbaum: Psychiatrist
Dr. Jeremey Tannenbaum is a Psychiatrist and Specialist Pain Medicine Physician trainee working in the public and private systems in Perth, Western Australia. His professional interests include the holistic management of persistent pain, interventional psychiatric treatments such as stellate ganglion blocks for PTSD, rTMS and ketamine infusions as well as the emerging therapeutic role of psychedelics. He is completing pain medicine training at Fiona Stanley and Hollywood Hospitals and The Anodyne Centre.
Prior to pain medicine, Jeremy completed his psychiatry fellowship in general adult psychiatry, with diverse experience in adult and child/youth mental health services, ranging from emergency psychiatry, inpatient units, private psychiatric and general hospital settings, mental health Hospital in the Home services and community adult clinics. Jeremy has also recently started working alongside the team at Emyria in a clinical advisory capacity.
As a medical student, he spent an elective with Professors David Nutt and Robin Carhart-Harris at Imperial College London, which encouraged his interest in the potential for psychedelics to help with managing difficult to treat mental health and other conditions.
Dr Stephen Bright: Psychologist/Psychedelic Reseacher
Dr. Stephen Bright is a Clinically trained psychologist who has worked in the field of Mental Health for the past 15 years. He is currently Senior Lecturer of Addiction at Edith Cowan University and is also an adjunct research fellow at Curtin University's National Drug Research Institute.
Dr. Bright has a longstanding professional involvement with psychedelics and is one of Australia’s foremost scientists in the field. Stephen is a founding member and vice-president of the organisation P.R.I.S.M. (Psychedelics Research In Science and Medicine). He is also due to become one of the first-ever Australians to successfully complete certification in MDMA-assisted psychotherapy - through training issued by the Multidisciplinary Association of Psychedelic Studies (MAPS).
Dr. Bright primarily identifies as an ethnopharmacologist, and the through-line that connects his various strands of work is the study of the ways in which humans interact with psychoactive substances - and how we can seek to optimize these complicated relationships.
Dr Niall Campbell:
Moderator
Dr. Niall Campbell is a former Dental Surgeon who originally qualified from Queens University Belfast with a Bachelor’s degree in Dental Surgery. After completing his General Professional Training in Oral Surgery Niall emigrated to Australia to work in Private Practice, specialising in the treatment of dentally anxious/phobic patients. Dissatisfied with the limitations of conventional pharmacological methods for the management of patient anxiety, Niall retrained in psychology and clinical hypnotherapy, prior to setting up primehypnosis.com - a psychotherapy and consulting service utilising non-ordinary states of consciousness for the treatment of addictions, phobias, and anxiety disorders.
Dr. Campbell has experience working as a psychotherapist in private residential AOD Rehab settings in Thailand, and has also served as Communications Manager for Asia Health Ltd, Content Strategist for District 34 (a Proptech company), and a Clinician at headpsace. Niall was part of the initial project management team to roll out Cambridge University’s ambitious Student Mental Health Plan during the 2019 Pandemic. Niall currently works as a behavior support practitioner serving clients with complex behavioural needs. Dr. Campbell has also volunteered at Synthesis Psilocybin retreat and as the host of the Mind manifest podcast, has interviewed some of the thought leaders in the current psychedelic renaissance.
“Alone, we can do so little; together, we can do so much”